|
BRACCO |
|
|
|
Isovue®
(iopamidol injection) |
|
Isovue® Prefilled
Syringes for use with the Medrad® injection systems
provide efficient contrast media use and administration
convenience. Isovue-370 is the highest concentration of
contrast approved for CT in the U.S. and is an excellent agent
to match the speed and power of MDCT. Isovue-M®
is indicated for myleography and is another example of the
Bracco commitment to support specialized imaging applications.
|
|
Isovue® -250 |
|
Each mL of
Isovue-250 (lopamidol Injection 51%) provides 510 mg iopamidol
with 1 mg tromethamine and 0. 33 mg edetate calcium disodium.
The solution contains approximately 0.036 mg (0.002 mEq) sodium
and 250 mg organically bound iodine per mL.
|
Cat No. |
Description
|
|
1317-05 |
10 x 50mL Vials / Box |
|
1317-02 |
10 x 100mL Bottles / Box |
|
1317-09 |
10 x 150mL Bottles / Box |
|
1317-41 |
10 x 200mL Bottles (Multi-Pack) / Box |
|
 |
|
Isovue® -
300 |
|
Each mL of
Isovue-300 (lopamidol Injection 61%) provides 612 mg iopamidol
with 1 mg tromethamine and 0.39 mg edetate calcium disodium. The
solution contains approximately 0.043 mg (0.002 mEq) sodium and
300 mg organically bound iodine per mL.
|
Cat No. |
Description
|
|
1315-25 |
10 x 30mL Vials / Box |
|
1315-30 |
10 x 50mL Vials / Box |
|
1315-47 |
10 x 75mL Bottles / Box |
|
1315-35 |
10 x 100mL Bottles / Box |
|
1315-50 |
10 x 150mL Bottles / Box |
|
1315-57 |
10 x 100mL Pre-Filled Syringes with
Pressure Tubing / Box |
|
1315-59 |
10 x 125mL Pre-Filled Syringes with
Pressure Tubing / Box |
|
1315-58 |
10 x 150mL Pre-Filled Syringes with
Pressure Tubing / Box |
|
1315-41 |
10 x 200mL Bottles (Multi-Pack) / Box |
|
1315-98 |
6 x 500mL Bottles (Multi-Pack) / Box |
|
|
|
Isovue® -370 |
|
Each mL of
Isovue-370 (lopamidol Injection 76%) provides 755 mg iopamidol
with 1 mg tromethamine and 0.48 mg edetate calcium disodium. The
solution contains approximately 0.053 mg (0.002 mEq) sodium and
370 mg organically bound iodine per mL.
|
Cat No. |
Description
|
|
1316-30 |
10 x 50mL Vials / Box |
|
1316-01 |
10 x 50mL Bottles / Box |
|
1316-52 |
10 x 75mL Bottles / Box |
|
1316-35 |
10 x 100mL Bottles / Box |
|
1316-04 |
10 x 125mL Bottles / Box |
|
1316-37 |
10 x 150mL Bottles / Box |
|
1316-40 |
10 x 200mL Bottles / Box |
|
1316-56 |
10 x 75mL Pre-Filled Syringes with
Pressure Tubing / Box |
|
1316-57 |
10 x 100mL Pre-Filled Syringes with
Pressure Tubing / Box |
|
1316-59 |
10 x 125mL Pre-Filled Syringes with
Pressure Tubing / Box |
|
1316-41 |
10 x 200mL Bottles (Multi-Pack) / Box |
|
1316-98 |
6 x 500mL Bottles (Multi-Pack) / Box |
|
 |
|
Isovue®
-M200 |
|
|
Cat No. |
Description
|
|
1411-11 |
10 x 10mL Vials / Box |
|
1411-25 |
10 x 25mL Vials / Box |
|
 |
|
Isovue® -300 |
|
|
Cat No. |
Description
|
|
1412-15 |
10 x 15mL Vials / Box |
|
|
|
MultiHance®
(gadobenate dimeglumine) injection |
|
MultiHance is an MRI contrast agent that has nearly twice the
relaxtivity of other gadolinium-based contrast agents providing
a marked increase in Signal-to-Noise Ratio (SNR) in T1-weighted
images. MultiHance demonstrates weak and transient
interactions with serum proteins that causes slowing in the
molecular tumbling dynamics, resulting in strong increases in
relaxivity in solutions containing serum proteins. The
improved relaxation effect could potentially contribute to
improved visualization.
|
|
|
Cat No. |
Description
|
|
5164-12 |
5 x 5mL Vials / Pack |
|
5164-13 |
5 x 10mL Vials / Pack |
|
5164-14 |
5 x 15mL Vials / Pack |
|
5164-15 |
5 x 20mL Vials / Pack |
|
5264-16 |
5 x 50mL Bottles (Multi-Pack) |
|
5264-17 |
5 x 100mL Bottles (Multi-Pack) |
|
 |
|
Gastrografin®
|
|
A
palatable lemon-flavored, water-soluble iodinated radiopaque
contrast medium for oral or rectal administration used for
radiographic examination of segments of the gastrointestinal
tract and as an adjunct to contrast enhancement in CT of the
torso. |
|
|
Cat No. |
Description
|
|
0445-35 |
24 x 30mL Bottles / Box |
|
0445-40 |
12 x 120mL Bottles / Box |
|
 |
|
Reno-30 |
|
Indicated
for retrograde or ascending pyelography. This procedure
may be used if intravenous excretion urography is
contraindicated and it is also useful in complementing other
diagnostic information.
|
Cat No. |
Description
|
|
0804-45 |
25 x 50mL Vials / Box |
|
0804-44 |
10 x 50mL Vials / Box |
|
|
Reno-60 |
|
Indicated
in excretion urography (by direct I.V. or drip infusion);
cerebral angiography; peripheral arteriography; venography;
operative, T-tube, or percutaneous transhepatic cholangiography;
splenoportography; arthrography and enhanced computed tomography
(CT) of the brain and the body.
|
Cat No. |
Description
|
|
0696-49 |
10 x 50mL Vials / Box |
|
|
Reno-DIP |
|
Indicated for
use in drip infusion pyelography in those patients in whom
routine pyelography would not be expected to be, or has not
been, satisfactory for diagnosis. It is not intended to replace
retrograde pyelography where this procedure is indicated.
Reno-DIP is also indicated for radiographic contrast enhancement
in computed tomography (CT) of the brain and body.
|
Cat No. |
Description
|
|
0809-75 |
10 x 300mL Bottles / Box |
|
|
Renografin®-60 |
|
Indicated in
excretion urography (by direct I.V. or drip infusion); cerebral
angiography; peripheral arteriography; venography; operative,
T-tube, or percutaneous transhepatic cholangiography;
splenoportography; arthrography; and discography and enhanced
computed tomography (CT) of the brain and the body.
|
|
|
Cat No. |
Description
|
|
0707-49 |
10 x 50mL Vials / Box |
|
0707-55 |
10 x 100mL Bottles / Box |
|
 |
|
Sinografin® |
|
Indicated
for use in hysterosalpingography. |
|
|
Cat No. |
Description
|
|
0523-30 |
10 x 10mL Vials / Box |
|
 |
|
Cystografin®
Dilute |
|
Indicated
for retrograde cystourethrography. |
|
|
Cat No. |
Description
|
|
1410-30 |
10 x 300mL Bottles / Box |
|
 |
|
Cystografin®
|
|
Indicated
for retrograde cystourethrography.
|
Cat No. |
Description
|
|
0149-60 |
10 x 100mL Bottles / Box |
|
0149-57 |
10 x 300mL Bottles / Box |
|
